⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Study of Neoadjuvant Nivolumab + Palbociclib + Anastrozole in Post-Menopausal Women and Men With Primary Breast Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Study of Neoadjuvant Nivolumab + Palbociclib + Anastrozole in Post-Menopausal Women and Men With Primary Breast Cancer

Official Title: Randomized, Non-comparative Neoadjuvant Phase II Study in Patients With ER+/HER2- Breast Cancer >= 2 cm With Safety Run-in, Assessing Nivolumab + Palbociclib + Anastrozole

Study ID: NCT04075604

Study Description

Brief Summary: A randomized multi-arm study evaluating the safety and efficacy of palbociclib and anastrozole with or without nivolumab in participants with ER+/HER2- breast cancer

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Local Institution - 0031, Whittier, California, United States

University Cancer Blood Ctr, Athens, Georgia, United States

Northside Hospital,Inc.- Central Research Department, Atlanta, Georgia, United States

Northwestern University, Chicago, Illinois, United States

Local Institution - 0041, Florham Park, New Jersey, United States

The Cancer Center At Hackensack University Medical Center, Hackensack, New Jersey, United States

MetroHealth Medical Center, Cleveland, Ohio, United States

Hematology-Oncology Associates Of Fredricksburg, Inc, Fredericksburg, Virginia, United States

Peninsula Cancer Institute, Newport News, Virginia, United States

Local Institution - 0005, Elizabeth Vale, South Australia, Australia

Breast Cancer Research Centre - WA, Nedlands, Western Australia, Australia

Local Institution - 0011, Wilrijk, Antwerpen, Belgium

Local Institution, Liege, , Belgium

Local Institution, Namur, , Belgium

Local Institution - 0071, Ottawa, Ontario, Canada

Local Institution - 0075, Bordeaux, , France

Local Institution - 0073, Creteil Cedex, , France

Local Institution - 0072, La Roche-sur-yon Cedex 9, , France

Centre Leon Berard, Lyon Cedex 08, , France

Local Institution - 0019, Marseille Cedex 9, , France

Centre de Cancerologie du Grand Montpellier, Montpellier, , France

Institut Claudius Regaud, TOULOUSE Cedex 9, , France

Local Institution, Bonn, , Germany

Local Institution, Erlangen, , Germany

Klinik Essen-Mitte, Essen, , Germany

Local Institution, Moenchengladbach, , Germany

Local Institution, Saarbruecken, , Germany

Local Institution - 0047, Monterrey Ponce, , Puerto Rico

Local Institution - 0002, San Juan, , Puerto Rico

Local Institution - 0062, San Juan, , Puerto Rico

H. Univ. Vall dHebron, Barcelona, , Spain

Local Institution - 0037, Barcelona, , Spain

Hosp Univer 12 De Octubre, Madrid, , Spain

Hospital Universitario Virgen De La Victoria, Malaga, , Spain

Hospital Universitario Virgen Del Rocio, Sevilla, , Spain

Hospital Clinico Universitario De Valencia, Valencia, , Spain

Contact Details

Name: Bristol-Myers Squibb

Affiliation: Bristol-Myers Squibb

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: